All data are based on the daily closing price as of May 16, 2025
e
Eiken Chemical
4549.TSE
13.76 USD
0.07
+0.51%
Overview
Last close
13.76 usd
Market cap
455.11M usd
52 week high
17.03 usd
52 week low
11.45 usd
Target price
15.79 usd
Valuation
P/E
31.1526
Forward P/E
N/A
Price/Sales
1.6315
Price/Book Value
1.5171
Enterprise Value
414.45M usd
EV/Revenue
1.4889
EV/EBITDA
10.8517
Key financials
Revenue TTM
278.37M usd
Gross Profit TTM
113.38M usd
EBITDA TTM
38.14M usd
Earnings per Share
0.44 usd
Dividend
0.36 usd
Total assets
406.73M usd
Net debt
-31.18M usd
About
Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.